Rationale for adjunctive topical corticosteroids in bacterial keratitis

Archives of Ophthalmology

Volumn 127, Issue 1, 2009, Pages 97-102

  Hindman, Holly B ^a   Patel, Sheel B ^a   Jun, Albert S ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CORTICOSTEROID DERIVATIVE; DEXAMETHASONE; DEXAMETHASONE ACETATE; DEXAMETHASONE SODIUM PHOSPHATE;

ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; CORNEA PERFORATION; CORNEA TRANSPLANTATION; CORNEA ULCER; HEALTH CARE COST; HUMAN; IMMUNE RESPONSE; INFECTION RISK; KERATITIS; KERATOPLASTY; MORBIDITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STAPHYLOCOCCUS AUREUS; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-BACTERIAL AGENTS; CORNEAL ULCER; DRUG THERAPY, COMBINATION; EYE INFECTIONS, BACTERIAL; GLUCOCORTICOIDS; HUMANS; OPHTHALMIC SOLUTIONS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 58449094955     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2008.504     Document Type: Review

References (76)

1. Thylefors B, Négrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull World Health Organ. 1995;73(1):115-121.
2. Erie JC, Nevitt MP, Hodge DO, Ballard DJ. Incidence of ulcerative keratitis in a defined population from 1950 through 1988. Arch Ophthalmol. 1993;111(12):1665-1671.
3. Dart JK, Stapleton F, Minassian D. Contact lenses and other risk factors in microbial keratitis. Lancet. 1991;338(8768):650-653.
4. Forster RK. Conrad Berens Lecture: the management of infectious keratitis as we approach the 21st century. CLAO J. 1998;24(3):175-180.
5. Lam DSC, Houang E, Fan DSP, Lyon D, Seal D, Wong E; Hong Kong Microbial Keratitis Study Group. Incidence and risk factors for microbial keratitis in Hong Kong: comparison with Europe and North America. Eye. 2002;16(5):608-618.
6. Wilhelmus KR. Indecision about corticosteroids for bacterial keratitis: an evidence-based update. Ophthalmology. 2002;109(5):835-842.
7. McDonnell PJ. Empirical or culture-guided therapy for microbial keratitis. Arch Ophthalmol. 1996;114(1):84-87.
8. Eye Bank Association of America. Eye Banking Statistical Report. Washington, DC: Eye Bank Association of America; 2000.
9. Chusid MJ, Davis SD. Experimental bacterial keratitis in neutropenic guinea pigs: polymorphonuclear leukocytes in corneal host defense. Infect Immun. 1979;24(3):948-952.
10. Gudmundsson OG, Ormerod LD, Kenyon KR, et al. Factors influencing predilection and outcome in bacterial keratitis. Cornea. 1989;8(2):115-121.
11. Coster DJ, Badenboch PR. Host, microbial, and pharmacological factors affecting the outcome of suppurative keratitis. Br J Ophthalmol. 1987;71(2):96-101.
12. Miedziak AI, Miller MR, Rapuano CJ, Laibson PR, Cohen EJ. Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology. 1999;106(6):1166-1170.
13. Morlet N, Minassian D, Butcher J. Risk factors for treatment outcome of suspected microbial keratitis. Br J Ophthalmol. 1999;83(9):1027-1031.
14. Hazlett LD, Moon MM, Strejc M, Berk RS. Evidence for N-acetylmannosamine as an ocular receptor for P. aeruginosa adherence to scarified cornea. Invest Ophthalmol Vis Sci. 1987;28(12):1978-1985.
15. Ramphal R, McNiece MT, Polack FM. Adherence of Pseudomonas aeruginosa to the injured cornea: a step in the pathogenesis of corneal infections. Ann Ophthalmol. 1981;13(4):421-425.
16. Burns RP, Rhodes DH Jr. Pseudomonas eye infection as a cause of death in premature infants. Arch Ophthalmol. 1961;65:517-525.
17. Singh A, Hazlett L, Berk RS. Characterization of Pseudomonal adherence to unwounded cornea. Invest Ophthalmol Vis Sci. 1991;32(7):2096-2104.
18. Stern GA, Weitzenkorn D, Valenti J. Adherence of Pseudomonas aeruginosa to the mouse cornea: epithelial v stromal adherence. Arch Ophthalmol. 1982;100(12):1956-1958.
19. Tjia KF, van Putten P, Pels E, Zanen HC. The interaction between Neisseria gonorrhoeae and the human cornea in organ culture: an electron microscopic study. Graefes Arch Clin Exp Ophthalmol. 1988;226(4):341-345.
20. Virji M, Makepeace K, Ferfuson DJ, Achtman M, Sarkari J, Moxon ER. Expression of Opc protein correlates with invasion of epithelial and endothelial cells by Neisseria meningitides. Mol Microbiol. 1992;6(19):2785-2795.
21. Chandler JW, Milam DF. Diptheria corneal ulcers. Arch Ophthalmol. 1978;96(1):53-56.
22. St Geme JW III, Falkow S. Haemophilus influenzae adheres to and enters cultured human epithelial cells. Infect Immun. 1990;58(12):4036-4044.
23. Rácz P, Tenner K, Szivessy K. Electron microscopic studies in experimental keratoconjunctivitis listeriosa, I: penetration of Listeria monocytogenes into corneal epithelial cells. Acta Microbiol Acad Sci Hung. 1970;17(3):221-236.
24. Labrec EH, Schneider H, Magnani TJ, Formal SB. Epithelial cell penetration as an essential step in the pathogenesis of bacillary dysentery. J Bacteriol. 1964;88(5):1503-1518.
25. O'Brien TP, Hazlett LD. Pathogenesis of ocular infection. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St Louis, MO: Mosby; 1996.
26. Wilhelmus KR. Bacterial keratitis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St Louis, MO: Mosby; 1996.
27. Drake D, Montie TC. Flagella, motility and invasive virulence of Pseudomonas aeruginosa. J Gen Microbiol. 1988;134(1):43-52.
28. Hyndiuk RA. Experimental Pseudomonas keratitis, I: sequential electron microscopy, II: comparative therapy trials. Trans Am Ophthalmol Soc. 1981;79:541-624.
29. Jones DB. Pathogenesis of bacterial and fungal keratitis. Trans Ophthalmol Soc U K. 1978;98(3):367-371.
30. Heck LW, Morihara K, Abrahamson DR. Degradation of soluble laminin and depletion of tissue-associated basement laminin by Pseudomonas aeruginosa elastase and alkaline protease. Infect Immun. 1986;54(1):149-153.
31. Cousins SW, Rouse BT. Inflammatory responses to ocular infection. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St Louis, MO: Mosby; 1996.
32. Fajardo LF. The complexity of endothelial cells: a review. Am J Clin Pathol. 1989;92(2):241-250.
33. Chusid MJ, Davis SD. Polymorphonuclear leukocyte kinetics in experimentally induced keratitis. Arch Ophthalmol. 1985;103(2):270-274.
34. Gray LD, Kreger AS. Rabbit corneal damage produced by Pseudomonas aeruginosa infection. Infect Immun. 1975;12(2):419-432.
35. Soya K, Obata H, Amano S, Miyata K, Tsuru T. Effects of topical corticosteroids on subepithelial haze after excimer laser corneal surgery: objective and quantitative method for evaluating haze [in Japanese]. Nippon Ganka Gakkai Zasshi. 1997;101(2):152-157.
36. Campos M, Abed HM, McDonnell PJ. Topical fluorometholone reduces stromal inflammation after photorefractive keratectomy. Ophthalmic Surg. 1993;24(10):654-657.
37. Wilhelmus KR, Gee L, Hauck WW, et al. Herpetic Eye Disease Study: a controlled trial of topical corticosteroids for Herpes simplex keratitis. Ophthalmology. 1994;101(12):1883-1895.
38. Steuhl KP, Döring G, Henni A, Thiel HJ, Botzenhart K. Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infections. Invest Ophthalmol Vis Sci. 1987;28(9):1559-1568.
39. Smolin G. Use of anti-inflammatory agents in destructive corneal disease. Trans Ophthalmol Soc U K. 1978;98(3):406-409.
40. Floman N, Zor U. Mechanism of steroid action in ocular inflammation: inhibition of prostaglandin production. Invest Ophthalmol Vis Sci. 1977;16(1):69-73.
41. Hayasaka Y, Hayasaka S, Zhang XY, Nagaki Y. Effects of topical corticosteroids and nonsteroidal anti-inflammatory drugs on prostaglandin e2-induced aqueous flare elevation in pigmented rabbits. Ophthalmic Res. 2003;35(6):341-344.
42. Eakins KE, Whitelocke RAF, Bennet A, Martenet AC. Prostaglandin-like activity in ocular inflammation. Br Med J. 1972;3(5824):452.
43. Green K, Paterson CA, Cheeks L, Slagle T, Jay WM, Aziz MZ. Ocular blood flow and vascular permeability in endo-toxin induced inflammation. Ophthalmic Res. 1990;22(5):287-294.
44. Foschi D, Castoldi L, Corsi F, Radaelli E, Trabucchi E. Inhibition of inflammatory angiogenesis in rats by loco-regional administration of hydrocortisone and protamine. Agents Actions. 1994;42(1-2):40-43.
45. Tommila P, Summanen P, Tervo T. Cortisone, heparin and argon laser in the treatment of corneal neovascularization. Acta Ophthalmol Suppl. 1987;182:89-92.
46. Leibowitz HM, Kupferman A. Anti-inflammatory effectiveness in the cornea of topically administered prednisolone. Invest Ophthalmol. 1974;13(10):757-763.
47. Kupferman A, Leibowtiz HM. Anti-inflammatory effectiveness of topically administered corticosteroids in the cornea without epithelium. Invest Ophthalmol. 1975;14(3):252-255.
48. Leibowitz HM, Lass JH, Kupferman A. Quantitation of inflammation in the cornea. Arch Ophthalmol. 1974;92(5):427-430.
49. Srinivasan BD, Kulkarni PS. Polymorphonuclear leukocyte response: inhibition following corneal epithelial denudation by steroidal and nonsteroidal anti-inflammatory agents. Arch Ophthalmol. 1981;99(6):1085-1089.
50. Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol. 2003;136(4):593-602.
51. Penfold PL, Wen L, Madigan MC, King NJ, Provis JM. Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells. Invest Ophthalmol Vis Sci. 2002;43(9):3125-3130.
52. Vemuganti GK, Reddy K, Iftekhar G, Garg P, Sharma S. Keratocyte loss in corneal infection through apoptosis: a histologic study of 59 cases. BMC Ophthalmol. 2004;4:16.
53. Brignole F, de Saint-Jean M, Goldschild M, et al. Expression of Fas-Fas ligand antigens and apoptotic marker APO2.7 by the human conjunctival epithelium: positive correlation with class II HLA DR expression in inflammatory ocular surface disorders. Exp Eye Res. 1998;67(6):687-697.
54. McDonald TO, Borgmann AR, Roberts MD, Fox LG. Corneal wound healing, I: inhibition of stromal healing by three dexamethasone derivatives. Invest Ophthalmol. 1970;9(9):703-709.
55. Sugar J, Chandler JW. Experimental corneal wound strength: effect of topically applied corticosteroids. Arch Ophthalmol. 1974;92(3):248-249.
56. Carmichael TR, Gelfand Y, Welsh NH. Topical steroids in the treatment of central and paracentral corneal ulcers. Br J Ophthalmol. 1990;74(9):528-531.
57. Leibowitz HM, Kupferman A. Antiinflammatory medications. Int Ophthalmol Clin. 1980;20(3):117-134.
58. Park SC, Kim JH. Effect of steroids and nonsteroidal anti-inflammatory agents on stromal wound healing following excimer laser keratectomy in rabbits. Ophthalmic Surg Lasers. 1996;27(5)(suppl):S481-S486.
59. Tani E, Katakami C, Negi A. Effects of various eye drops on corneal wound healing after superficial keratectomy in rabbits. Jpn J Ophthalmol. 2002;46(5):488-495.
60. Stern GA, Buttross M. Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease. Ophthalmology. 1991;98(6):847-853.
61. Leibowitz HM, Kupferman A. Topically administered corticosteroids: effect on antibiotic-treated bacterial keratitis. Arch Ophthalmol. 1980;98(7):1287-1290.
62. Gritz DC, Lee TY, Kwitko S, McDonnell PJ. Topical anti-inflammatory agents in an animal model of microbial keratitis. Arch Ophthalmol. 1990;108(7):1001-1005.
63. Lepri G. Studies on cortisone in ophthalmology. Am J Ophthalmol. 1952;35(7):935-946.
64. Gritz DC, Kwitko S, Trousdale MD, Gonzalez VH, McDonnell PJ. Recurrence of microbial keratitis concomitant with anti-inflammatory treatment in an animal model. Cornea. 1992;11(5):404-408.
65. Badenoch PR, Hay GJ, McDonald PJ, Coster DJ. A rat model of bacterial keratitis: effect of antibiotics and corticosteroid. Arch Ophthalmol. 1985;103(5):718-722.
66. Smolin G, Okumoto M, Leong-Sit L. Combined gentamicin-tobramycin- corticosteroid treatment, II: effect on gentamicin-resistant Pseudomonas keratitis. Arch Ophthalmol. 1980;98(3):473-474.
67. Engel LS, Callegan MC, Hobden JA, Reidy JJ, Hill JM, O'Callaghan RJ. Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res. 1995;14(3):229-234.
68. Ohadi C, Litwin KL, Moreira H. Antiinflammatory therapy and outcome in a guinea pig model of Pseudomonas keratitis. Cornea. 1992;11(5):398-403.
69. Hobden JA, Callaghan RJ, Hill JM, Hagenah M, Insler MS, Reidy JJ. Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis. Curr Eye Res. 1992;11(3):259-266.
70. Hobden JA, Engel LS, Hill JM, Callegan MC, O'Callaghan RJ. Prednisolone acetate or prednisolone phosphate concurrently administered for the therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res. 1993;12(5):469-473.
71. Davis SD, Sariff LD, Hyndiuk RA. Corticosteroid in experimentally induced Pseudomonas keratitis. Arch Ophthalmol. 1978;96(1):126-128.
72. Suie T, Taylor FW. The effect of cortisone on experimental Pseudomonas corneal ulcers. AMA Arch Ophthalmol. 1956;56(1):53-56.
73. Stern GA, Okumoto M, Friedlander M, Smolin G. The effect of combined gentamicin-corticosteroid treatment on gentamicin-resistant Pseudomonas keratitis. Ann Ophthalmol. 1980;12(9):1011-1014.
74. Fraser-Smith EB, Matthews TR. Effect of ketorolac on Pseudomonas aeruginosa ocular infection in rabbits. J Ocul Pharmacol. 1988;4(2):101-109.
75. Aronson SB, Moore TE Jr. Corticosteroid therapy in central stromal keratitis. Am J Ophthalmol. 1969;67(6):873-896.
76. Suwan-Apichon O, Reyes JM, Herretes S, Vedula SS, Chuck RS. Topical corticosteroids as adjunctive therapy for bacterial keratitis. Cochrane Database Syst Rev. 2007;(4):CD005430.